FANG-JU LINChang, Ting-YuTing-YuChangJUNG-YIEN CHIEN2020-10-122020-10-122020-0600123692https://scholars.lib.ntu.edu.tw/handle/123456789/516782animation[SDGs]SDG3beta 2 adrenergic receptor stimulating agent; corticosteroid; fluticasone propionate plus salmeterol; corticosteroid; chronic obstructive lung disease; disease exacerbation; disease severity; drug efficacy; drug safety; drug use; eosinophil count; human; Letter; medical decision making; outcome assessment; pneumonia; priority journal; risk factor; scoring system; treatment outcome; chronic obstructive lung disease; Adrenal Cortex Hormones; Humans; Pulmonary Disease, Chronic Obstructiveletter10.1016/j.chest.2020.02.05532505317WOS:000539236600050